Sites in US, Europe, Asia plan to participate in a Study Comparing Diagnostic Performance of Ultra-low Radiation Dose to CT scans reconstructed with current techniques
CHICAGO, ILLINOIS -- November 30, 2009 -- GE Healthcare, a $17 billion unit of General Electric Company (NYSE:GE), announced today a multi-center study to investigate the performance of Model Based Iterative Reconstruction (MBIR) as a method to maintain or improve diagnostic information available to clinicians while dramatically lowering radiation dose in routine CT imaging.
business unit
GE also highlights enhanced features of LOGIQ P6, Voluson E8 architecture enhancement, Venue 40 product launch and improved ultrasound data management in the ViewPoint Breakthrough 2010
CHICAGO, ILLINOIS -- November 29, 2009 -- GE Healthcare, a $17 billion unit of General Electric Company (NYSE:GE), announced new breakthrough technologies at the Radiological Society of North America (RSNA) annual meeting in Chicago, Ill.
business unit
tags
Commitment to creating technology to deliver healthier experiences for the caregiver and the patient
CHICAGO, ILLINOIS, NOVEMBER 29, 2009 -- Miniaturized ultrasound. Navigation during interventional procedures. Innovations in sound wave imaging. At RSNA 2009, GE Healthcare is finding better ways to see more. And using that information to do more.
business unit
tags
GE lets customers choose the technology they need now, with the opportunity to add features to extend clinical value
CHICAGO, ILLINOIS -- November 29, 2009 -- At the Radiological Society of North America (RNSA) meeting today, GE Healthcare, a $17 billion unit of General Electric Company (NYSE: GE), introduced the Senographe® Essential® e mammography system and the 3 Mega-pixel (MP) monitor as expansions of their mammography portfolio.
Senographe Essential Family
business unit
tags
By providing cutting-edge research applications and complete infrastructure solutions, GE helps industry understand disease from the beginning
CHICAGO, ILLINOIS -- NOVEMBER 28, 2009 -- As the world becomes more educated and advanced in molecular medicine, the healthcare industry is experiencing a growing convergence of therapeutics and diagnostics. GE Healthcare, a $17 billion unit of General Electric Company (NYSE:GE), is at the forefront of this convergence with the latest in radiopharmacy and pre-clinical innovations.
business unit
GE Healthcare demonstrates its commitment to both clinicians and researchers by introducing improvements in predictability, efficiency, and confidence across the 600 series portfolio
CHICAGO, ILLINOIS -- NOVEMBER 28, 2009 -- GE Healthcare, a $17 billion unit of unit of General Electric Company (NYSE:GE), announced dual detector capabilities and an enhanced application suite for its DiscoveryTM PET/CT 600 series scanners, at the 2009 Radiological Society of North America (RSNA) in Chicago, Illinois.